The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients

Diana Hedevang Christensen1 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark;2 Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, DenmarkCorrespondence[email protected]

Erzsébet Horváth-Puhó1 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

Morten Schmidt1 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

Christian Fynbo Christiansen1 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

Lars Pedersen1 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

Bente Lomholt Langdahl2 Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Reimar Wernich Thomsen1 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

show all

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date